Tumor microenvironment
101 – 110 of 1974
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
- Contribution to journal › Article
-
Mark
Hypoxic induction of exosome uptake through proteoglycan-dependent endocytosis fuels the lipid droplet phenotype in Glioma
- Contribution to journal › Article
-
Mark
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
- Contribution to journal › Article
-
Mark
An observational study on the molecular profiling of primary melanomas reveals a progression dependence on mitochondrial activation
- Contribution to journal › Article
-
Mark
Cancer Cells Can Exhibit a Sparing FLASH Effect at Low Doses Under Normoxic In Vitro-Conditions
- Contribution to journal › Article
-
Mark
Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomized clinical trial
- Contribution to journal › Article
- 2020
-
Mark
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
- Contribution to journal › Article
-
Mark
The pleiotropic role of proteoglycans in extracellular vesicle mediated communication in the tumor microenvironment
- Contribution to journal › Scientific review
-
Mark
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
- Contribution to journal › Article
-
Mark
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery : 20-Year Follow-up of the Randomized SweBCGRT Trial
- Contribution to journal › Article
